- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Paul Hauptman, MD, Addresses Patient-Focused Outcomes in Heart Failure
Paul Hauptman, MD, Professor of Internal Medicine, Division of Cardiology, Health Management & Policy, School of Public Health, Saint Louis University School of Medicine, says that clinicians tend to focus on non-patient focused outcomes.
Paul Hauptman, MD, Professor of Internal Medicine, Division of Cardiology, Health Management & Policy, School of Public Health, Saint Louis University School of Medicine, says that clinicians tend to focus on non-patient focused outcomes.
Dr Hauptman says the challenge is incorporating the scores from various instruments, such as quality of life measurements, and translating them into a meaningful intervention for the patients.
This video was taken at the American College of Cardiology's 62nd Annual Scientific Session & Expo in San Francisco, CA, on March 9, 2013.
Finding the Right Biomarker Is Key to the TIGIT Puzzle, Experts Say
May 12th 2025Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, align with recent bad news for this once-promising therapeutic target. But investigators involved in TIGIT studies say the problem is finding the right biomarker.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Intermountain Healthcare and Story Health Partner to Optimize Rural Heart Failure Care
February 7th 2023On this episode of Managed Care Cast, we speak with Tom Stanis, CEO and cofounder of Story Health, and Phillip Wood, Intermountain Ventures program director, on how their partnership came about, how it is going so far, and the future of their collaboration.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
